C13orf24
From Wikipedia, the free encyclopedia
|
Chromosome 13 open reading frame 24
|
|||||
| Identifiers | |||||
| Symbol(s) | C13orf24; KIAA1008; PIBF1; RP11-505F3.1 | ||||
| External IDs | OMIM: 607532 MGI: 1261910 HomoloGene: 4628 | ||||
|
|||||
| RNA expression pattern | |||||
| Orthologs | |||||
| Human | Mouse | ||||
| Entrez | 10464 | 52023 | |||
| Ensembl | ENSG00000083535 | ENSMUSG00000022064 | |||
| Uniprot | Q8WXW3 | n/a | |||
| Refseq | NM_006346 (mRNA) NP_006337 (protein) |
NM_029320 (mRNA) NP_083596 (protein) |
|||
| Location | Chr 13: 72.25 - 72.49 Mb | Chr 14: 97.98 - 98.14 Mb | |||
| Pubmed search | [1] | [2] | |||
Chromosome 13 open reading frame 24, also known as C13orf24, is a human gene.[1]
[edit] References
[edit] Further reading
- Szekeres-Bartho J, Barakonyi A, Par G, et al. (2001). "Progesterone as an immunomodulatory molecule.". Int. Immunopharmacol. 1 (6): 1037–48. PMID 11407300.
- Szekeres-Bartho J, Varga P, Pejtsik B (1990). "ELISA test for the detection of an immunological blocking factor in human pregnancy serum.". J. Reprod. Immunol. 16 (1): 19–29. PMID 2600930.
- Szekeres-Bartho J, Faust Z, Varga P (1996). "The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes.". Am. J. Reprod. Immunol. 34 (6): 342–8. PMID 8607938.
- Check JH, Arwitz M, Gross J, et al. (1997). "Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF).". Am. J. Reprod. Immunol. 37 (1): 17–20. PMID 9138449.
- Check JH, Arwitz M, Gross J, et al. (1997). "Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception.". Am. J. Reprod. Immunol. 38 (1): 6–8. PMID 9266004.
- Harrington JJ, Sherf B, Rundlett S, et al. (2001). "Creation of genome-wide protein expression libraries using random activation of gene expression.". Nat. Biotechnol. 19 (5): 440–5. doi:. PMID 11329013.
- Rozenblum E, Vahteristo P, Sandberg T, et al. (2002). "A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes.". Hum. Genet. 110 (2): 111–21. doi:. PMID 11935316.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Polgar B, Kispal G, Lachmann M, et al. (2004). "Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.". J. Immunol. 171 (11): 5956–63. PMID 14634107.
- Dunham A, Matthews LH, Burton J, et al. (2004). "The DNA sequence and analysis of human chromosome 13.". Nature 428 (6982): 522–8. doi:. PMID 15057823.
- Polgár B, Nagy E, Mikó E, et al. (2005). "Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.". Biol. Reprod. 71 (5): 1699–705. doi:. PMID 15269099.
- Lachmann M, Gelbmann D, Kálmán E, et al. (2004). "PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.". Int. J. Cancer 112 (1): 51–60. doi:. PMID 15305375.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Kozma N, Halasz M, Palkovics T, Szekeres-Bartho J (2006). "The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca.". Am. J. Reprod. Immunol. 55 (2): 122–9. doi:. PMID 16433831.

